Article info

Original research
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors

Authors

  1. Correspondence to Dr Björn Frendéus; bjorn.frendeus{at}bioinvent.com
View Full Text

Citation

Semmrich M, Marchand J, Fend L, et al
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors

Publication history

  • Accepted December 27, 2021
  • First published January 19, 2022.
Online issue publication 
January 19, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.